"MAKING TRIALS BETTER, TOGETHER" Triumph has developed a capability that allows companies running clinical trials to deliver consistently, efficiently and in a controlled manner to either their own, or industry standard metrics. We work with Biopharma, CRO and Medical Device companies, and partner with industry leading systems vendors, such as Oracle, Medidata and Tibco. Triumph takes an innovative, pragmatic and results oriented approach to everything we do. Our consultants have all come from the Pharma and CRO industries and understand the challenges faced from management, end user, and regulatory perspectives. Triumph Consultancy Services was established in 2002, and is based in Stansted, UK, and Raleigh, NC in the USA. Triumph is dedicated to improving clinical trials and invests heavily in new approaches, tools and services to help us drive towards achieving our mission: "To enhance the quality, experience and value of clinical trials for both industry and patients" Our mission is simple, and with you we can make it a reality. In 2013, the executive management team of Triumph founded TRI, or Triumph Research Intelligence, which is the first and only company dedicated entirely to quality oversight and risk-based monitoring. Specifically, TRI on the foundation of 13 years consulting services which is still very much alive today, built the OPRA risk-based monitoring platform which is the first purpose built platform in the RBM space. Be sure to follow TRI by searching LinkedIn with this specific text: "TRI - Triumph Research Intelligence, The Risk-Based Monitoring Company", have a look at our website, tritrials.com, and check us out on twitter @TRI_OPRA_RBM Lastly, we encourage you to join the official risk-based monitoring LinkedIn group by copy/pasting the following test in your browser: https://www.linkedin.com/grp/home?gid=8180947&trk=my_groups-tile-grp TRI - Where's The Risk?